Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-12-30 4:27 pm Sale | 13D | ALPINE IMMUNE SCIENCES INC ALPN | ORBIMED ADVISORS LLC | 3,216,206 13.4% | -600,000 (-15.72%) | View |
| 2020-12-23 4:09 pm Purchase | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Avidity Partners Management LP | 1,337,413 5.6% | 1,337,413 (New Position) | View |
| 2020-12-22 5:16 pm Sale | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Alpine ImmunoSciences L.P. | 4,212,608 17.1% | -527,620 (-11.13%) | View |
| 2020-08-06 4:47 pm Purchase | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Omega Fund IV L.P. | 1,670,370 6.9% | 1,670,370 (New Position) | View |
| 2020-07-31 7:49 pm Purchase | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 4,409,721 17.7% | 563,132 (+14.64%) | View |
| 2020-07-31 7:48 pm Purchase | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Alpine ImmunoSciences L.P. | 4,740,228 19.4% | 224,832 (+4.98%) | View |
| 2020-07-30 8:16 pm Purchase | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Frazier Life Sciences VIII L.P. | 2,737,101 11.5% | 11,475 (+0.42%) | View |
| 2020-07-30 6:26 pm Unchanged | 13D | ALPINE IMMUNE SCIENCES INC ALPN | ORBIMED ADVISORS LLC | 3,816,206 16% | 0 (Unchanged) | View |
| 2020-02-14 2:48 pm Sale | 13G | ALPINE IMMUNE SCIENCES INC ALPN | BIOTECHNOLOGY VALUE FUND L P | 1,137,764 6.1% | -63,954 (-5.32%) | View |